liver cancer

South Korean scholars on the 14th that hepatitis B patients in the interleukin-10 (INTERLEUKIN10) after gene mutation can cause liver cancer.
This discovery is South Korea, Seoul National University School of Medicine Xiao Shi leadership of the SNP Research Group and South Korea's Research Group after more than two years of cooperative research on that.Research Group of 1,078 patients with clinical cases of hepatitis B, of which 270 patients with worsening of the illness, to become liver cancer.By measuring and comparing these genes in patients on the order of the nucleotide differences, the team eventually led us to the interleukin-10 gene.They found that the infection of hepatitis B and turn into liver cancer patients, about 20% of the patients in a gene variation of the phenomenon, and the mutations with the average age of liver cancer than other people ahead of 10 around.Initial studies confirmed that the same patients suffering from Hepatitis B, and the illness was a result of the development of the gene mutation or different results.
Study Group pointed out that the study explained the hepatitis B patients suffering from liver cancer more easily Part of the reason for.Further research will be proven in hepatocellular carcinoma role in the formation of other genes, so that the medical profession can be more accurate forecast of a hepatitis B patients in the risk of liver cancer.